Evercore Wealth Management’s Acorda Therapeutics ACOR Stock Holding History

Evercore Wealth Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3	Closed	-$8K	–	1050
2016 Q4	$8K	Hold	3	–	–	﹤0.01%	847
2016 Q3	$8K	Hold	3	–	–	﹤0.01%	895
2016 Q2	$10K	Hold	3	–	–	﹤0.01%	853
2016 Q1	$11K	Hold	3	–	–	﹤0.01%	802
2015 Q4	$17K	Hold	3	–	–	﹤0.01%	795
2015 Q3	$11K	Hold	3	–	–	﹤0.01%	829
2015 Q2	$13K	Hold	3	–	–	﹤0.01%	862
2015 Q1	$13K	Hold	3	–	–	﹤0.01%	846
2014 Q4	$16K	Hold	3	–	–	﹤0.01%	701
2014 Q3	$14K	Hold	3	–	–	﹤0.01%	791
2014 Q2	$13K	Hold	3	–	–	﹤0.01%	808
2014 Q1	$15K	Hold	3	–	–	﹤0.01%	787
2013 Q4	$12K	Hold	3	–	–	﹤0.01%	749
2013 Q3	$14K	Hold	3	–	–	﹤0.01%	727
2013 Q2	$13K	Buy	+3	New	+$12.4K	﹤0.01%	704

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Evercore Wealth Management's ACOR Position: Q1 2017 in Review

Evercore Wealth Management sold out of Acorda Therapeutics (ACOR) in Q1 2017, closing a stake of 3 shares — an estimated $8K sold.

Evercore Wealth Management first reported a position in ACOR in Q2 2013 and held it in 15 quarters. The position peaked at $17K in Q4 2015. 178 funds tracked by Wall St. Rank hold ACOR as of Q1 2017.

Evercore Wealth Management reported no remaining Acorda Therapeutics position as of Q1 2017 after selling out during the quarter.
Evercore Wealth Management sold 3 Acorda Therapeutics shares in Q1 2017, an estimated $8K.
Evercore Wealth Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 15 quarters.
Evercore Wealth Management's Acorda Therapeutics position peaked at $17K in Q4 2015.
178 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2017.

Based on Evercore Wealth Management's 13F filing for Q1 2017, filed 15 May 2017.